Dogwood Therapeutics DWTX Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash

Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash at other companies

GATXGATX

$1.75M+243%

CarGurus, Inc.CARG

-$613K-186%

ADTRAN Holdings, Inc.ADTN

-$2.56M-2,024%

Achieve Life SciencesACHV

$4K—

Franklin CoveyFC

$205K—

SPS CommerceSPSC

$288K-56.4%

Other financials

Income statement

See full

Operating income-$5.1M-14.6%

Net income-$5.0M+54.4%

EPS (diluted)-$0.15+98.2%

Balance sheet

See full

Cash & equivalents$13.2M-24.6%

Total debt$144.9K-24.2%

Total equity$80.6M+1,038%

Total assets$95.2M-1.8%

Cash flow

See full

Operating cash flow-$4.6M+2.0%

Valuation

See full

Market cap$54.14M-57.6%

Enterprise value$41.06M-64.7%

Returns & leverage

See full

Return on equity-64.6%-29.8pp

Debt / equity0×0.0×

Current ratio5.9×-1.6×

Where this comes from

Reported directly by Dogwood Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dogwood Therapeutics's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dogwood Therapeutics's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash?: Dogwood Therapeutics (DWTX) reported effect of currency exchange rate changes on cash, cash equivalents, and restricted cash of -$1.04K in Q1 2026.
How has Dogwood Therapeutics's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash changed year-over-year?: Dogwood Therapeutics's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash decreased by 184.7% year-over-year, from $1.23K to -$1.04K.